查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
鼻息肉治療市場：成長、未來前景、競爭分析，2024-2032
市場調查報告書
商品編碼
1507939

鼻息肉治療市場：成長、未來前景、競爭分析，2024-2032

Nasal Polyps Treatment Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
出版日期: | 出版商: Acute Market Reports | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

鼻息肉治療市場包括所有用於治療鼻息肉的醫療和外科幹預措施，鼻息肉是在鼻腔和鼻竇內壁形成的非癌性生長物。這些息肉會引起鼻塞、慢性鼻塞、鼻竇炎和嗅覺下降等症狀。該市場包括多種治療選擇，例如皮質類固醇、抗生素、抗組織胺、鼻噴劑以及息肉切除術和內視鏡鼻竇手術等外科手術。治療與鼻息肉相關的急性和慢性疾病，並為廣泛的人群提供服務，包括不同年齡層和症狀嚴重程度的患者。由於全球人口中鼻竇炎和相關鼻部併發症的盛行率不斷增加，鼻息肉治療市場穩步成長。由於鼻息肉與慢性鼻竇炎密切相關，呼吸道感染、過敏和其他免疫相關疾病的增加促進市場擴張。此外，診斷技術的進步提高了鼻息肉的檢出率，提高了治療採用率。由於治療方法的不斷改進和對該疾病的認識不斷提高，該市場預計將以 5.5%的年複合成長率（CAGR）成長。微創手術技術的創新為嚴重和復發性鼻息肉病例提供有效的解決方案，縮短恢復時間並減少併發症，也推動了市場成長。

鼻息肉治療市場的關鍵驅動因素是全球慢性鼻竇炎和過敏反應盛行率的上升。慢性鼻竇炎通常伴隨鼻息肉，影響很大一部分人群，導致持續症狀，嚴重影響生活品質。美國疾病管制與預防中心（CDC）估計，美國每年約有 2,890 萬名成年人被診斷出患有慢性鼻竇炎，有效治療的必要性已廣泛認可。由於環境變化和接觸過敏原的增加，過敏現象呈上升趨勢，而過敏與鼻息肉發展之間的相關性進一步增加了對治療的需求。這些鼻竇相關疾病的持續增加推動對醫療和外科幹預措施的持續需求，維持市場成長。

擴大治療選擇與市場進入

鼻息肉治療市場的商機在於擴大治療選擇和簡化市場准入。近年來，鼻息肉的藥物治療取得了很大進展，包括生物製劑的引進，已有效縮小鼻息肉並改善重症患者的症狀。這些新療法為對皮質類固醇和手術等傳統療法沒有反應的患者提供了另一種選擇。此外，隨著全球（尤其是發展中國家）醫療保健基礎設施的改善，獲得這些先進治療方法的機會日益增加。這種擴張不僅擴大了市場的地理範圍，而且擴大了患者可用的治療選擇範圍，並有可能提高市場滲透率和採用率。

應對治療的快速進展

研究方法市場面臨的一個關鍵挑戰是需要適應治療方法的快速發展。新的藥物治療和外科技術的發展需要醫療專業人員不斷更新他們的知識和技能。這種持續的發展可能會給缺乏資源跟上最新發展的醫療保健提供者和系統帶來壓力。此外，隨著製藥業迅速轉向個人化醫療，越來越需要將新的診斷和治療方案納入日常臨床實踐。跟上這些進步需要在培訓和技術方面進行大量投資，這對於已經受到各種經濟和後勤限制的醫療保健系統來說可能是一個挑戰。

依治療類型細分市場

鼻息肉治療市場依治療類型分為藥物治療及手術治療。藥物治療預計將在市場上產生最高的收入，這主要是由於皮質類固醇和新生物製劑的擴散。這些治療可有效減少發炎和息肉大小，使其成為治療的首選，並提供了廣泛患者首選的非侵入性選擇。此外，目的是治療嚴重病例發炎根本原因的標靶生物製劑的迅速普及也為該部門的收入做出了重大貢獻。另一方面，包括內視鏡鼻竇手術和息肉切除術在內的外科手術預計將經歷最高的年複合成長率。這種成長是由手術技術的進步所推動的，這些技術允許更有效和更少侵入性的手術，縮短嚴重或復發性鼻息肉患者的恢復時間並改善結果，導致手術幹預的壓力增加。

依最終用戶：市場區隔

依最終使用者劃分，鼻息肉治療市場分為醫院、門診手術中心及專科診所。醫院預計將產生最高的收入，因為它們是可以提供藥物和外科治療的綜合設施。醫院是進行更複雜手術的主要中心，可以獲得廣泛的服務和專科，吸引了大量需要廣泛治療的患者。另一方面，門診手術中心的年複合成長率預計最高。此細分市場的成長是由門診手術護理的日益轉變所推動的。門診手術治療比住院治療便宜，恢復時間也更快。這些中心為不太嚴重的鼻息肉手術提供了高效的環境，並吸引了尋求便利而無需長期住院的患者。

區域分析

地理細分揭示了鼻息肉治療市場各地區的不同趨勢。由於其先進的醫療基礎設施、對鼻部健康問題的高度認識以及成熟的製藥行業，北美被認為是2023年銷售額比率最高的地區。該地區的優勢也得益於有利的償付政策和早期採用生物製劑等創新療法。同時，預計2024年至2032年亞太地區的年複合成長率最高。該地區的快速成長歸因於醫療保健成本上升、醫療保健獲取機會的改善、過敏和鼻竇炎患病率的上升以及醫療保健基礎設施的改善，特別是在中國和印度等新興國家。

競爭趨勢

從競爭趨勢來看，鼻息肉治療市場包括Sanofi、Merck KGaA、OptiNose US, Inc.、Intersect ENT, Inc.、Pfizer, Inc.、Regeneron Pharmaceuticals Inc.、Novartis AG、GSK plc、F. Hoffmann-La Roche Ltd.等大公司。2023年，這些公司將重點放在策略聯盟、推進新療法的研究和開發、擴大地理影響力以鞏固其市場地位。例如，Pfizer和Regeneron致力於與鼻息肉相關的特定發炎途徑的生物療法的創新，這推動了可觀的收入來源。展望未來，從2024年到2032年，這些公司預計將增加對新興市場的投資，進一步完善標靶治療，並利用數位工具實現更好的疾病管理和患者參與。這些公司的策略目的是滿足全球市場對更有效、侵入性更小的治療日益成長的需求，並致力於透過藥物開發和手術解決方案的創新來加強其產品組合。

本報告回答的主要問題

影響鼻息肉治療市場成長的關鍵微觀和宏觀環境因素有哪些？

在目前和預測期間內，產品領域和地區的主要投資領域是什麼？

2032年之前的預估與市場預測

哪個細分市場在預測期間內年複合成長率最快？

哪個細分市場擁有較大的市場佔有率，為什麼？

中低收入國家是否投資鼻息肉治療市場？

鼻息肉治療市場最大的區域市場是哪一個？

亞太地區、拉丁美洲和中東、非洲等新興市場的市場趨勢和動態是什麼？

推動鼻息肉治療市場成長的主要趨勢是什麼？

主要競爭對手有哪些，以及他們提高在全球鼻息肉治療市場佔有率的關鍵策略是什麼？

目錄

第1章 前言

  • 報告內容
    • 報告的目的
    • 目標受眾
    • 主要優惠
  • 市場區隔
  • 調查方法
    • 第一階段-二次調查
    • 第二階段-初步調查
    • 第三階段-專家評審
    • 先決條件
    • 採用的方法

第2章 執行摘要

第3章 鼻息肉治療市場：競爭分析

  • 主要供應商的市場定位
  • 供應商採取的策略
  • 主要產業戰略
  • 層級分析：2023年與2032年

第4章 鼻息肉治療市場：宏觀分析與市場動態

  • 簡介
  • 2022-2032年世界鼻息肉治療市場價值
  • 市場動態
    • 市場驅動因素
    • 市場限制因素
    • 主要挑戰
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • See-Saw分析
  • 波特的五力模型
    • 供應商實力
    • 買家力量
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的對抗關係
  • PESTEL 分析
    • 政治局勢
    • 經濟情勢
    • 技術版圖
    • 法律狀況
    • 社會狀況

第5章 鼻息肉治療市場：依治療類型2022-2032

  • 市場概覽
  • 成長/利潤分析：2023年與2032年
  • 市場區隔
    • 藥物治療
      • 皮質類固醇
      • 抗生素
      • 白三烯抑制劑
      • 其他
    • 手術
      • 息肉切除術
      • 功能性內視鏡鼻竇手術（FESS）

第6章 鼻息肉治療市場：依最終使用者劃分，2022-2032年

  • 市場概覽
  • 成長/利潤分析：2023年與2032年
  • 市場區隔
    • 醫院
    • 門診手術中心
    • 專科診所

第7章 2022-2032年北美鼻息肉治療市場

  • 市場概覽
  • 鼻息肉治療市場：依治療類型，2022-2032年
  • 鼻息肉治療市場：依最終用戶，2022-2032年
  • 鼻息肉治療市場：依地區，2022-2032年
    • 北美
      • 美國
      • 加拿大
      • 其他北美地區

第8章 英國與歐盟鼻息肉治療市場2022-2032

  • 市場概覽
  • 鼻息肉治療市場：依治療類型，2022-2032年
  • 鼻息肉治療市場：依最終用戶，2022-2032年
  • 鼻息肉治療市場：依地區，2022-2032年
    • 英國和歐盟
      • 英國
      • 德國
      • 西班牙
      • 義大利
      • 法國
      • 其他歐洲地區

第9章 亞太鼻息肉治療市場2022-2032

  • 市場概覽
  • 鼻息肉治療市場：依治療類型，2022-2032年
  • 鼻息肉治療市場：依最終用戶，2022-2032年
  • 鼻息肉治療市場：依地區，2022-2032年
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 其他亞太地區

第10章 2022-2032年拉丁美洲鼻息肉治療市場

  • 市場概覽
  • 鼻息肉治療市場：依治療類型，2022-2032年
  • 鼻息肉治療市場：依最終用戶，2022-2032年
  • 鼻息肉治療市場：依地區，2022-2032年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

第11章 2022-2032年中東及非洲鼻息肉治療市場

  • 市場概覽
  • 鼻息肉治療市場：依治療類型，2022-2032年
  • 鼻息肉治療市場：依最終用戶，2022-2032年
  • 鼻息肉治療市場：依地區，2022-2032年
    • 中東、非洲
      • 海灣合作委員會
      • 非洲
      • 其他中東、非洲地區

第12章 公司簡介

  • Sanofi
  • Merck & Co Inc.
  • OptiNose US Inc.
  • Intersect ENT Inc.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Novartis AG
  • GSK plc.
  • F. Hoffmann-La Roche Ltd
Product Code: 708-07-24

The nasal polyps treatment market encompasses all medical and surgical interventions used to treat nasal polyps, which are non-cancerous growths on the lining of the nasal passages or sinuses. These polyps can cause symptoms such as nasal blockage, chronic congestion, sinusitis, and reduced sense of smell. The market includes a range of treatment options such as corticosteroids, antibiotics, antihistamines, nasal sprays, and surgical procedures like polypectomy and endoscopic sinus surgery. It serves a broad demographic that includes patients from varying age groups and severities of symptoms, addressing both acute and chronic conditions associated with nasal polyps. The nasal polyps treatment market is experiencing steady growth, attributed to the increasing prevalence of sinusitis and related nasal complications among the global population. As nasal polyps are closely associated with chronic sinusitis, the rise in respiratory tract infections, allergies, and other immune-related conditions contributes to the market's expansion. Furthermore, advancements in diagnostic technologies have improved the detection rates of nasal polyps, leading to an increase in treatment adoption. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.5%, driven by continuous improvements in medical treatments and growing awareness of the condition. Innovations in minimally invasive surgical techniques, which offer faster recovery times and reduced complications, also bolster the market growth, providing effective solutions for severe and recurrent cases of nasal polyps.

Rising Prevalence of Chronic Sinusitis and Allergic Reactions A significant driver for the nasal polyps treatment market is the rising prevalence of chronic sinusitis and allergic reactions globally. Chronic sinusitis, often associated with nasal polyps, affects a large segment of the population, leading to persistent symptoms that severely impact quality of life. The Centers for Disease Control and Prevention (CDC) estimates that approximately 28.9 million adults in the United States are diagnosed with chronic sinusitis annually, underscoring the extensive need for effective treatment options. The correlation between allergies and the development of nasal polyps further amplifies the demand for treatments as allergies continue to rise due to environmental changes and increased exposure to allergens. This ongoing increase in sinus-related conditions drives the continuous demand for both medical and surgical interventions, sustaining market growth.

Expansion of Treatment Options and Market Accessibility

An opportunity within the nasal polyps treatment market lies in the expansion of treatment options and market accessibility. Recent years have seen significant advancements in the pharmacological treatment of nasal polyps, including the introduction of biologics, which have been effective in reducing polyp size and improving symptoms in patients with severe cases. These new treatments provide an alternative for patients who are unresponsive to traditional therapies such as corticosteroids or surgery. Furthermore, as healthcare infrastructure improves globally, particularly in developing countries, there is increased access to these advanced treatments. This expansion not only broadens the market geographically but also enhances the range of therapeutic options available to patients, potentially increasing market penetration and adoption rates.

High Cost of Treatment The high cost of treatment poses a significant restraint on the nasal polyps treatment market. Advanced treatments, particularly biologic therapies, are expensive and may not be accessible to all segments of the population, especially in less developed healthcare systems. The cost barrier is compounded in regions without comprehensive health insurance systems or adequate public healthcare funding, where patients may need to pay out of pocket. This financial barrier can limit the growth of the market by restricting the user base to only those who can afford these advanced treatments, thereby impeding broader adoption and accessibility.

Adapting to Rapid Advances in Treatment

A critical challenge facing the nasal polyps treatment market is the need to adapt to rapid advances in treatment methodologies. The development of new pharmacological treatments and surgical techniques requires practitioners to continuously update their knowledge and skills. This ongoing evolution can strain healthcare providers and systems that might lack the resources to keep pace with the latest developments. Additionally, with the pharmaceutical industry moving rapidly towards personalized medicine, there is a growing need to integrate new diagnostic and treatment protocols into everyday clinical practice. Keeping up with these advancements necessitates significant investment in training and technology, which can be a daunting challenge for healthcare systems already under pressure from various economic and logistical constraints.

Market Segmentation By Type of Treatment

The nasal polyps treatment market can be segmented by the Type of Treatment into Pharmacological Therapies and Surgeries. Pharmacological Therapies are expected to command the highest revenue within the market, primarily driven by the widespread use of corticosteroids and newer biologic medications. These therapies are the first line of treatment due to their effectiveness in reducing inflammation and size of polyps, offering a non-invasive option that is preferable for a broad patient base. The surge in the adoption of targeted biologic therapies, which are designed to treat underlying causes of inflammation in severe cases, also contributes significantly to the revenue of this segment. Meanwhile, Surgeries, including endoscopic sinus surgery and polypectomy, are projected to witness the highest CAGR. This growth is attributed to the advancements in surgical techniques, which have become more effective and less invasive, leading to reduced recovery times and improved outcomes for patients with severe or recurrent nasal polyps, thereby increasing the preference for surgical interventions.

Market Segmentation By End-users

In terms of End-users, the nasal polyps treatment market is segmented into Hospitals, Ambulatory Surgical Centers, and Specialty Clinics. Hospitals are anticipated to generate the highest revenue due to their comprehensive facilities capable of offering both pharmacological and surgical treatments. Hospitals serve as the primary center for more complex surgeries and have access to a wide range of services and specialties, which attracts a larger patient demographic requiring extensive treatment. On the other hand, Ambulatory Surgical Centers are expected to experience the highest CAGR. The growth in this segment is driven by the increasing shift towards outpatient surgical care, which is less costly and offers faster recovery times compared to in-hospital stays. These centers provide an efficient setting for surgeries with less severe cases of nasal polyps, appealing to patients seeking convenience without prolonged hospitalization.

Geographical Analysis

In the nasal polyps treatment market, geographic segmentation reveals varied trends across regions. North America is noted for generating the highest revenue percentage in 2023, attributed to its advanced healthcare infrastructure, high awareness of nasal health issues, and the presence of a well-established pharmaceutical industry. This region's dominance is also supported by favorable reimbursement policies and the early adoption of innovative treatments such as biologics. Meanwhile, Asia-Pacific is expected to witness the highest CAGR from 2024 to 2032. The rapid growth in this region can be attributed to increasing healthcare expenditures, greater access to medical treatment, rising prevalence of allergies and sinusitis, and improving healthcare infrastructure, particularly in emerging economies such as China and India.

Competitive Trends

In terms of competitive trends, the nasal polyps treatment market includes key players like Sanofi, Merck & Co, Inc., OptiNose US, Inc., Intersect ENT, Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Novartis AG, GSK plc, and F. Hoffmann-La Roche Ltd. In 2023, these companies focused on strategic collaborations, advancing R&D for new treatment modalities, and expanding their geographical presence to strengthen market positions. For instance, Pfizer and Regeneron had emphasized innovation in biologic therapies targeting specific inflammatory pathways associated with nasal polyps, which significantly drove their revenue streams. Moving forward, from 2024 to 2032, these companies are expected to increase investments in emerging markets, further refine targeted therapies, and leverage digital tools for better disease management and patient engagement. Their strategies will likely focus on enhancing product portfolios through innovation in drug development and surgical solutions, aiming to meet the growing demand for more effective and minimally invasive treatments across the global market.

Historical & Forecast Period

This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Nasal Polyps Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Nasal Polyps Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

    • Type of Treatment
  • Pharmacological Therapies

Corticosteroids

Antibiotics

Leukotriene Inhibitors

Others

  • Surgeries

Polypectomy

Functional Endoscopic Sinus Surgery (FESS)

    • End-user
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Nasal Polyps Treatment market?

What are the key investment pockets concerning product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Nasal Polyps Treatment market?

Which is the largest regional market for Nasal Polyps Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Nasal Polyps Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Nasal Polyps Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Nasal Polyps Treatment Market
  • 2.2. Global Nasal Polyps Treatment Market, By Type of Treatment, 2023 (US$ Million)
  • 2.3. Global Nasal Polyps Treatment Market, By End-user, 2023 (US$ Million)
  • 2.4. Global Nasal Polyps Treatment Market, By Geography, 2023 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2023

3. Nasal Polyps Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Nasal Polyps Treatment Market Vendors
  • 3.2. Strategies Adopted by Nasal Polyps Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Nasal Polyps Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Nasal Polyps Treatment Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Market Segmentation
    • 5.3.1. Pharmacological Therapies
      • 5.3.1.1. Corticosteroids
      • 5.3.1.2. Antibiotics
      • 5.3.1.3. Leukotriene Inhibitors
      • 5.3.1.4. Others
    • 5.3.2. Surgeries
      • 5.3.2.1. Polypectomy
      • 5.3.2.2. Functional Endoscopic Sinus Surgery (FESS)

6. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Market Segmentation
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Specialty Clinics

7. North America Nasal Polyps Treatment Market, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
  • 7.3. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
  • 7.4.Nasal Polyps Treatment Market: By Region, 2022-2032, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 7.4.1.1.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 7.4.1.2.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 7.4.1.3.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)

8. UK and European Union Nasal Polyps Treatment Market, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
  • 8.3. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
  • 8.4.Nasal Polyps Treatment Market: By Region, 2022-2032, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 8.4.1.1.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 8.4.1.2.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 8.4.1.3.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 8.4.1.4.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 8.4.1.5.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 8.4.1.6.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)

9. Asia Pacific Nasal Polyps Treatment Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
  • 9.3. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
  • 9.4.Nasal Polyps Treatment Market: By Region, 2022-2032, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 9.4.1.1.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 9.4.1.2.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 9.4.1.3.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 9.4.1.4.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 9.4.1.5.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 9.4.1.6.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)

10. Latin America Nasal Polyps Treatment Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
  • 10.3. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
  • 10.4.Nasal Polyps Treatment Market: By Region, 2022-2032, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 10.4.1.1.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 10.4.1.2.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 10.4.1.3.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)

11. Middle East and Africa Nasal Polyps Treatment Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
  • 11.3. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
  • 11.4.Nasal Polyps Treatment Market: By Region, 2022-2032, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 11.4.1.1.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 11.4.1.2.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Nasal Polyps Treatment Market: By Type of Treatment, 2022-2032, USD (Million)
        • 11.4.1.3.2. Nasal Polyps Treatment Market: By End-user, 2022-2032, USD (Million)

12. Company Profile

  • 12.1. Sanofi
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Merck & Co, Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. OptiNose US, Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Intersect ENT, Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Pfizer Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Regeneron Pharmaceuticals Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Novartis AG
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. GSK plc.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. F. Hoffmann-La Roche Ltd
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 2 Global Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 3 Global Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 4 Global Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 5 North America Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 6 North America Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 7 North America Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 8 North America Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 9 U.S. Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 10 U.S. Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 11 U.S. Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 12 U.S. Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 13 Canada Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 14 Canada Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 15 Canada Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 16 Canada Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 17 Rest of North America Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 18 Rest of North America Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 19 Rest of North America Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 20 Rest of North America Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 21 UK and European Union Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 22 UK and European Union Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 23 UK and European Union Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 24 UK and European Union Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 25 UK Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 26 UK Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 27 UK Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 28 UK Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 29 Germany Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 30 Germany Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 31 Germany Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 32 Germany Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 33 Spain Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 34 Spain Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 35 Spain Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 36 Spain Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 37 Italy Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 38 Italy Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 39 Italy Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 40 Italy Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 41 France Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 42 France Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 43 France Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 44 France Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 45 Rest of Europe Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 46 Rest of Europe Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 47 Rest of Europe Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 48 Rest of Europe Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 49 Asia Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 50 Asia Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 51 Asia Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 52 Asia Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 53 China Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 54 China Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 55 China Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 56 China Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 57 Japan Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 58 Japan Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 59 Japan Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 60 Japan Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 61 India Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 62 India Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 63 India Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 64 India Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 65 Australia Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 66 Australia Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 67 Australia Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 68 Australia Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 69 South Korea Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 70 South Korea Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 71 South Korea Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 72 South Korea Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 73 Latin America Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 74 Latin America Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 75 Latin America Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 76 Latin America Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 77 Brazil Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 78 Brazil Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 79 Brazil Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 80 Brazil Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 81 Mexico Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 82 Mexico Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 83 Mexico Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 84 Mexico Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 85 Rest of Latin America Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 86 Rest of Latin America Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 87 Rest of Latin America Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 88 Rest of Latin America Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 89 Middle East and Africa Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 90 Middle East and Africa Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 91 Middle East and Africa Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 92 Middle East and Africa Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 93 GCC Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 94 GCC Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 95 GCC Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 96 GCC Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 97 Africa Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 98 Africa Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 99 Africa Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 100 Africa Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

  • TABLE 101 Rest of Middle East and Africa Nasal Polyps Treatment Market By Type of Treatment, 2022-2032, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Nasal Polyps Treatment Market By Pharmacological Therapies, 2022-2032, USD (Million)

TABLE 103 Rest of Middle East and Africa Nasal Polyps Treatment Market By Surgeries, 2022-2032, USD (Million)

TABLE 104 Rest of Middle East and Africa Nasal Polyps Treatment Market By End-user, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Nasal Polyps Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Nasal Polyps Treatment Market: Quality Assurance
  • FIG. 5 Global Nasal Polyps Treatment Market, By Type of Treatment, 2023
  • FIG. 6 Global Nasal Polyps Treatment Market, By End-user, 2023
  • FIG. 7 Global Nasal Polyps Treatment Market, By Geography, 2023
  • FIG. 8 Market Geographical Opportunity Matrix - Global Nasal Polyps Treatment Market, 2023

FIG. 9Market Positioning of Key Nasal Polyps Treatment Market Players, 2023

FIG. 10Global Nasal Polyps Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 11 Global Nasal Polyps Treatment Market, By Type of Treatment, 2023 Vs 2032, %
  • FIG. 12 Global Nasal Polyps Treatment Market, By End-user, 2023 Vs 2032, %
  • FIG. 13 U.S. Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 14 Canada Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 15 Rest of North America Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 16 UK Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 17 Germany Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 18 Spain Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 19 Italy Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 20 France Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 21 Rest of Europe Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 22 China Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 23 Japan Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 24 India Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 25 Australia Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 26 South Korea Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 27 Rest of Asia Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 28 Brazil Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 29 Mexico Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 30 Rest of Latin America Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 31 GCC Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 32 Africa Nasal Polyps Treatment Market (US$ Million), 2022 - 2032
  • FIG. 33 Rest of Middle East and Africa Nasal Polyps Treatment Market (US$ Million), 2022 - 2032